Yep both Martin and Roger need to go. For starters I don`t like the fact the company has not performed to expectation and Roger seems to have too many roles, jobs other than OSL. Taken from the OSL website; "Dr Aston is currently a director and Chairman of Immuron Limited (ASX:IMC), Director and Chairman of Regeneus Limited (ASX:RGS) and Director and Chairman of ResApp Limited (ASX:RAP). Roger Aston’s principal activity is as Executive Chairman of Pharmaust Ltd (ASXAA)". He is not delivering and needs to move on.
Are they both up for re-election soon? Let us shareholders vote against them when we get the next chance to do so.
OSL Price at posting:
5.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
AA)". He is not delivering and needs to move on.
(20min delay)